Akari Therapeutics PLC <AKTX.OQ> expected to post a loss of 11 cents a share - Earnings Preview
Akari Therapeutics PLC AKTX.OQ AKTX.O is expected to report results for the period ending September 30 2025
LSEG's mean analyst estimate for Akari Therapeutics PLC is for a loss of 11 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The average consensus recommendation for the pharmaceuticals peer group is also "Buy".
Wall Street's median 12-month price target for Akari Therapeutics PLC is $6.00, about 83.8% above its last closing price of $0.97
This summary was machine generated August 15 at 20:42 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
Oracle Q1 FY2026 Earnings: Cloud Surge and Record RPO Fuel AI Optimism
TradingKey - Oracle Corporation (NYSE: ORCL) posted mixed Q1 FY2026 results, with total revenue and adjusted EPS slightly below consensus amid a shift to cloud services, but cloud revenue beat expectations with robust 28% growth. A massive RPO backlog of $455 billion, up 359% YoY
Will iPhone 17 Spark a New Upgrade Cycle? The Baseline iPhone Excites, But the Air Could Flop
TradingKey - After Apple’s 2025 fall launch event, Apple’s stock (AAPL) turned from gains to losses, as investors once again expressed dissatisfaction with what they saw as a lack of major innovation from the world’s top tech innovator. Analysts’ reviews suggest that the upgraded base iPhone 17
U.S. August CPI Preview: Persistent Rise in Inflation, What Impact on Rate Cuts? And on US Stocks?
TradingKey - On 11 September 2025, the U.S. will publish August CPI data. Consensus forecasts indicate a 0.3% month-over-month increase for both headline CPI and core CPI. As a result, headline CPI year-over-year may climb to 2.9%, up from 2.7%
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks ahead
2025 Hottest US IPO Week: Klarna, Gemini, Figure Set for “Triple Launch”
TradingKey - 5 companies are now pricing their U.S. initial public offerings (IPOs) for the week starting September 8, with a total expected fundraising exceeding $3 billion, making it the busiest IPO week of 2025. Investors are closely watching the debut performance of Klarna, Gemini, and Figure.
